All News
Does diet drive IL-23 in IBD and PsA? Perhaps if you have the right baseline risk. The science is evolving quickly
Stronger rationale that diet may be really important in some patients
#EULAR2022 #IL23 @RheumNow https://t.co/hV54PvfOXV
David Liew drdavidliew ( View Tweet)
Incidentally looked at the FLORA study in @RheumNow Tuesday Night Rheumatology for ‘PsA All The Way’, a month before #EULAR2022
https://t.co/s5qa4breCf
https://t.co/a52myvJMMc
David Liew drdavidliew ( View Tweet)
Watch: AURORA-2 Two-year Results Voclosporin For Lupus Nephritis
https://t.co/k61KOBXRSl
#EULAR2022 https://t.co/Q7cjqvQyFG
Links:
Dr. John Cush RheumNow ( View Tweet)
“Modify medications, work on lifestyle (weight loss/exercise), and emphasize patience.”
- Prof van Lear on managing difficult to treat RA
#EULAR2022 @rheumnow
TheDaoIndex KDAO2011 ( View Tweet)
#COVID19 #pandemic has affected #rheumatology training
Negative impact on
▶️Learning
▶️Research
▶️Mental health
▶️Physical health
👉🏽https://t.co/Irtkg8TjZt
By @kristenyoung @SuAnnYeoh1 @EBRheum @SattuiSEMD @RichardPAConway @SituationRheum @KilianMD @rheum_covid et al @RheumJnl https://t.co/wysWzE92Fm
Dr Ai Lyn Tan DrAiLynTan ( View Tweet)
These findings suggest a pathogenic link between airway inflammation in bronchiectasis and RA-related autoantibodies
Jeffrey Sparks MD MMSc jeffsparks ( View Tweet)
controls were n=360. typo
Jeffrey Sparks MD MMSc jeffsparks ( View Tweet)
Prof van Lear noted 5-10% of pts have D2T RA; the highest risk factor is low socieconomic status. D2T RA have higher comorbidities and healthcare utilization #EULAR2022 @rheumnow https://t.co/PhPjhksyI4 https://t.co/JCByho4ubk
TheDaoIndex KDAO2011 ( View Tweet)
Associations with RA-BR (n=57 cases) compared to RA-no lung disease controls (n=36)
⬆️⬆️⬆️RF level (OR 4.4)
⬆️⬆️ ACPA level (OR 3.5)
⬆️older age at RA onset (OR 1.37 per 10 years)
⬇️ BMI (OR 0.94 per kg/m2) (i.e., higher risk in underweight)
🚫 associations: sex, smoking pk-yrs
Jeffrey Sparks MD MMSc jeffsparks ( View Tweet)
Difficult to treat rheumatoid arthritis is expensive - to the health system, but also to society #EULAR2022 @RheumNow https://t.co/eM2Ih3kGL7
David Liew drdavidliew ( View Tweet)
🧨 Factors associated w/ Pulmonary Embolism in ORAL surveillance:
⚡️history of VTE ⚡️antidepressant use
⚡️BMI≥30
⚡️corticosteroid use
⚡️male gender
⚡️age ≥65
⚡️Hx of Hypertension
⚡️hormonal ttmt use
POS0239 #EULAR2022 @RheumNow https://t.co/pT6MDAUbjH
Aurelie Najm AurelieRheumo ( View Tweet)
Prof van Lear reviews #EULAR ’s 11 points to consider for difficult to treat RA (D2T RA) published here https://t.co/zOLiMChjx8 #EULAR2022 @rheumnow (1/n) https://t.co/mVjJ5A1VkW
TheDaoIndex KDAO2011 ( View Tweet)
Dr. E. Loza reminds #EULAR2022 that it is important to measure response of patients when using clinical guidelines for treatment! It will help us adapt guidelines for the future to help patients. @RheumNow https://t.co/pMkpsMH44U
Dr. Rachel Tate uptoTate ( View Tweet)
The reference is at https://t.co/Auwrimc0jt
Dr. Antoni Chan synovialjoints ( View Tweet)
Eun et al. South Korean population based study. n=138,592 RA patients. aHR dementia 1.19 (95%CI 1.16–1.23), Alzheimers 1.21 (95%CI 1.67-1.25), Vascular dementia 1.10 (95%CI 0.99-1.21) @RheumNow #EULAR2022 OP0271 https://t.co/URNYnYzuF6
Links:
Richard Conway RichardPAConway ( View Tweet)
Razmjou et al. Survival in RA-ILD patients with lung transplant comparable to other cohorts. Not surprisingly UIP pattern trended to worse outcome HR 7.13, p=0.06 @RheumNow #EULAR2022 OP0275 https://t.co/RJ1nMkHwRh https://t.co/iUENMhqiX3
Links:
Richard Conway RichardPAConway ( View Tweet)
Case reports of tofacitinib efficacy for calcinosis over last couple of years. Benefits were relatively quickly (within 3m) reported by Jiri Vencovsky #eular2022
Alberta Hoi alberta_hoi ( View Tweet)
Lisa Rider suggests that calcinosis is more commonly seen in JDM than adults maybe the result of the more prominent vasculopathy and IFN signature. #EULAR2022
Alberta Hoi alberta_hoi ( View Tweet)
Always satisfying to see the big plenary hall in full flight #EULAR2022 @RheumNow https://t.co/DkzZCFvFw7
David Liew drdavidliew ( View Tweet)
SLE trials update
Translating targeted therapy from bench to bedside has been more problematic in SLE than other autoimmune diseases.
https://t.co/xmYbgOplsm https://t.co/QUrtwAJqNl
Links:
Dr. John Cush RheumNow ( View Tweet)